학술논문
RISK OF DEATH AND COPD HOSPITALIZATION WITH FLUTICASONE FUROATE-CONTAINING THERAPY: POST HOC SUBGROUP ANALYSIS FROM THE SUMMIT TRIAL IN PATIENTS WITH COPD AND A HISTORY OF EXACERBATION
Document Type
Abstract
Author
Source
In Chest October 2020 158(4) Supplement:A1755-A1760
Subject
Language
ISSN
0012-3692